^○Young-Eun OH^{1, 2}, Vishwanath Vasudev PRABHU^{1, 2}, Thong Ba NGUYEN^{1, 2}, Fatimazahra RAMI^{1, 2}, Young-Chul CHUNG^{1, 2} (1. Department of Psychiatry, Chonbuk National University Medical School, Jeonju, South Korea, 2. Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, South Korea)

^○Hikaru KOIZUMI^{1, 3}, Kaoruko AICHI¹, Akihiro MOURI^{4, 5}, Toshitaka NABESHIMA^{5, 6}, Hideaki SOYA^{1, 2} (1. Laboratory of Exercise Biochemistry and Neuroendocrinology, Faculty of Health and Sport Sciences, University of Tsukuba, Japan, 2. Department of Sports Neuroscience, Advanced Research Initiative for Human High Performance (ARIHHP), Faculty of Health and Sport Sciences, University of Tsukuba, 3. The Japan Society for the Promotion of Science, 4. Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Graduate School of Health Sciences, Fujita Health University, Aichi, Japan, 5. Japanese Drug Organization of Appropriate Use and Research, Nagoya, Japan, 6. Advanced Diagnostic System Research Laboratory, Graduate School of Health Sciences, Fujita Health University, Aichi, Japan)

^○Marco Andrea RIVA ¹, Paola BRIVIO¹, Giulia SBRINI¹, Maria Serena PALADINI², Vittoria SPERO², Mariusz PAPP³, Raffaella MOLTENI², Francesca CALABRESE¹ (1. Department of pharmacological and biomolecular sciences, University of Milan, 2. Department of Medical Biotechnologies and Translational Medicine, University of Milan, 3. Institute of Pharmacology, Polish Academy of Sciences, Krakow)

^○Hisayoshi KUBOTA¹, Akihiro MOURI¹, Kazuo KUNISAWA¹, Moe NIIJIMA¹, Mami HIRAKAWA¹, Yuko MORI², Yasuko YAMAMOTO², Toshitaka NABESHIMA³, Kuniaki SAITO^{2, 3} (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan., 2. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan., 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan.)

^○Kohei TAKAHASHI^{1, 2}, Osamu NAKAGAWASAI¹, Wakana SAKUMA¹, Wataru NEMOTO¹, Takayo ODAIRA¹, Jia-Rong LIN¹, Hiroshi ONOGI³, Lalit K. SRIVASTAVA⁴, Minoru TSUJI², Hiroshi TAKEDA², Koichi TAN-NO¹ (1. Department of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Miyagi, Japan, 2. Department of Pharmacology, School of Pharmacy, International University of Health and Welfare, Tochigi, Japan., 3. Faculty of Health Science, Tohoku Fukushi University, Miyagi, Japan., 4. Department of Psychiatry, Douglas Mental Health Universit Institute, McGill University, Montreal, Canada)

^○Kazuya TORIUMI¹, Kazuhiro SUZUKI^{1, 2}, Mai ASAKURA¹, Mitsuhiro MIYASHITA¹, Yasue HORIUCHI¹, Akiko KOBORI¹, Masanari ITOKAWA¹, Makoto ARAI¹ (1. Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Department of Psychiatry, Shinshu University School of Medicine)

^○Atsuko HAYATA^{1, 2}, Harui KIJIMA², Yusuke SHINTANI², Takanobu NAKAZAWA^{2, 3}, Hitoshi HASHIMOTO^{1, 2, 4, 5} (1. Molecular Research Center for Children’s Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, 2. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 3. Depertment of Pharmacology, Graduate School of Dentistry, Osaka University, 4. Instisute for Datability Science, Osaka University, 5. Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University)